stockrowBiodesix, Inc. (BDSX) vs Fulgent Genetics, Inc. (FLGT)
- Biodesix, Inc. BDSX 19.84 −7.68%
- Fulgent Genetics, Inc. FLGT 18.66 −5.18%
Biodesix, Inc. and Fulgent Genetics, Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $513.4M against $209.3M — 2.5× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 31.2% against 4.67%. Biodesix, Inc. has the higher net margin (−25.7% vs −27.5%) and the lower return on invested capital (−44.8% vs −8.22%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 11 and Biodesix, Inc. on 7.
Valuation
Profitability
| Metric | BDSX | FLGT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 0.00% | 33.82% | 48.32% |
| Operating margin | (18.69%) | (39.20%) | (5.68%) |
| Net margin | (25.74%) | (27.53%) | (4.10%) |
| Free cash flow margin | (18.30%) | 4.37% | 0.00% |
| Return on equity | (778.89%) | (8.64%) | 0.00% |
| Return on assets | (29.65%) | (7.93%) | (6.05%) |
| Return on invested capital | (44.84%) | (8.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack